Detalhe da pesquisa
1.
Primary ciliary dyskinesia gene contribution in Tunisia: Identification of a major Mediterranean allele.
Hum Mutat
; 41(1): 115-121, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31469207
2.
GATA2 gene analysis in several forms of hematological malignancies including familial aggregations.
Ann Hematol
; 96(10): 1635-1639, 2017 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-28752392
3.
Mutational analysis of JAK2, CBL, RUNX1, and NPM1 genes in familial aggregation of hematological malignancies.
Ann Hematol
; 95(7): 1043-50, 2016 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-27106701
4.
Familial hematological malignancies: new IDH2 mutation.
Ann Hematol
; 95(12): 1943-1947, 2016 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-27591990
5.
Minimal Residual Disease assessment of IDH1/2 mutations in Acute Myeloid Leukemia by LNA-RQ-PCR.
Tunis Med
; 94(3): 190-7, 2016 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-27575502
6.
Phytochemical Composition, Antioxidant, and Anticancer Activities of Sidr Honey: In Vitro and In Silico Computational Investigation.
Life (Basel)
; 13(1)2022 Dec 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-36675984
7.
An overview of genetic predisposition to familial hematological malignancies.
Bull Cancer
; 108(7-8): 718-724, 2021.
Artigo
em Inglês
| MEDLINE | ID: mdl-34052033
8.
Mutational analysis of apoptotic genes in familial aggregation of hematological malignancies.
Bull Cancer
; 108(9): 798-805, 2021 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-34140154
9.
A novel DNAH5 variant in a Tunisian patient with primary ciliary dyskinesia.
J Genet
; 992020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32089523
10.
Quantification of JAK2V617F mutation by next-generation sequencing technology.
Am J Hematol
; 88(6): 536-7, 2013 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-23553621
11.
Mutational analysis of TP53 gene in Tunisian familial hematological malignancies and sporadic acute leukemia cases.
Fam Cancer
; 16(1): 153-157, 2017 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27619989
12.
ARLTS1, potential candidate gene in familial aggregation of hematological malignancies.
Bull Cancer
; 104(2): 123-127, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27866680
13.
Chemiluminescent detection of clonal immunoglobulin and T cell receptor gene rearrangements in Tunisian lymphoid malignancies, leukemias and lymphomas.
Leuk Lymphoma
; 47(6): 1129-37, 2006 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-16840206
14.
Combined IKZF1 and IG markers as new tools for diagnosis and minimal residual disease assessment in Tunisian B-ALL.
Bull Cancer
; 103(10): 822-828, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27614734
15.
Insight into TPMT(∗)23 mutation mis-folding using molecular dynamics simulation and protein structure analysis.
J Biomol Struct Dyn
; 31(10): 1066-76, 2013 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-23025308
16.
Minimal residual disease monitoring based on FLT3 internal tandem duplication in adult acute myeloid leukemia.
Leuk Res
; 36(3): 316-23, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22129478
17.
Gene alterations in the PI3K/PTEN/AKT pathway as a mechanism of drug-resistance (review).
Int J Oncol
; 40(3): 639-44, 2012 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-22200790
18.
Understanding rituximab function and resistance: implications for tailored therapy.
Front Biosci (Landmark Ed)
; 16(2): 770-82, 2011 01 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-21196202
19.
Molecular study of the perforin gene in familial hematological malignancies.
Hered Cancer Clin Pract
; 9(1): 9, 2011 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-21936944